×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Jeevan Scientific Technology L | 127.35 | 0.46 | 125.07 | 0.03 | 77.3 | 131.0 |
| SUNIL HEALTHCARE LTD | 209.95 | -5.41 | 204.64 | -0.53 | 68.4 | |
| Aspira Pathlab & Diagnostics L | 54.96 | 3.06 | 54.07 | 0.30 | 66.5 | 78.2 |
Jeevan Scientific Technology Limited, with Security Code 538837, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.3 | 7.9 | 9.9 | 7.9 | 10.3 | 8.0 | 10.1 | 9.9 | 12.5 | 10.3 |
| Expenses | 9.0 | 8.4 | 8.5 | 9.0 | 8.3 | 7.4 | 9.0 | 9.4 | 9.1 | 8.4 |
| Operating Profit | 1.3 | -0.4 | 1.5 | -1.0 | 2.0 | 0.7 | 1.1 | 0.6 | 3.4 | 1.9 |
| OPM % | 12.44% | -5.21% | 14.69% | -13.12% | 19.7% | 8.33% | 10.78% | 5.54% | 27.09% | 18.88% |
| Other Income | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | -0.1 | 0.3 | 0.1 | 0.2 |
| Interest | 0.3 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.3 |
| Depreciation | 1.1 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.3 | 1.4 | 1.3 | 1.3 |
| Profit before tax | 0.2 | -1.6 | 0.2 | -2.4 | 0.7 | -0.7 | -0.5 | -0.8 | 2.1 | 0.6 |
| Tax % | 119.4% | -25% | 71.9% | -6.2% | 20% | -27.6% | -21.4% | -3.5% | 22.7% | 74.5% |
| Net Profit | 0.4 | -1.2 | 0.1 | -2.3 | 0.6 | -0.5 | -0.4 | -0.7 | 1.6 | 0.2 |
| EPS in Rs | 0.25 | -0.83 | 0.04 | -1.47 | 0.36 | -0.32 | -0.25 | -0.48 | 1.03 | 0.1 |
| Metrics | Dec 2021 | Mar 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.0 | 11.9 | 7.9 | 10.4 | 8.1 | 10.1 | 11.1 | 12.9 | 11.4 | 12.5 |
| Expenses | 14.3 | 14.0 | 9.0 | 8.4 | 7.5 | 9.1 | 10.1 | 9.7 | 8.9 | 10.4 |
| Operating Profit | 6.7 | -2.1 | -1.0 | 2.0 | 0.6 | 1.0 | 1.0 | 3.2 | 2.5 | 2.1 |
| OPM % | 32.1% | -17.7% | -13.2% | 19.5% | 7.5% | 10% | 8.8% | 25% | 21.9% | 16.6% |
| Other Income | 0.4 | 5.1 | 0.3 | 0.3 | 0.3 | -0.1 | 0.2 | 0.1 | 0.2 | 0.2 |
| Interest | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.1 | 0.3 | 0.3 | 0.5 | 0.4 |
| Depreciation | 1.0 | 0.7 | 1.4 | 1.5 | 1.4 | 1.4 | 1.6 | 1.5 | 1.5 | 1.5 |
| Profit before tax | 5.9 | 2.1 | -2.5 | 0.6 | -0.8 | -0.6 | -0.8 | 1.5 | 0.7 | 0.4 |
| Tax % | 27.8% | 70.6% | -6.2% | 19.3% | -26% | -24.1% | -3.6% | 31.3% | 65.2% | 88.3% |
| Net Profit | 4.3 | 0.6 | -2.3 | 0.5 | -0.6 | -0.5 | -0.7 | 1.0 | 0.3 | 0.0 |
| EPS in Rs | 2 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 9% |
| 3 Years: | -2% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 152% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 20% |
| 3 Years: | -30% |
| 1 Year: | -15% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | -5% |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 121% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 20% |
| 3 Years: | -30% |
| 1 Year: | -15% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|